Investors & Media International Stem Cell Corporation Applauds President Obama's Decision to Allow Funding of Parthenogenetic Stem Cell Research International Stem Cell Corporation Hosts Webinar, "Stem Cells 102: Beyond Embryonic Stem Cell Research," Thursday, March 12, 2009, From 1:00pm-2:00pm EDT DiscoveryBioMed, Inc. Engaged in Multiple Projects on Behalf of Lifeline Cell Technology, Inc. to Test the Function and Utility of Multiple Primary Human Cell Products International Stem Cell Corporation Issues Letter to Shareholders International Stem Cell Corporation Featured In The Economist International Stem Cell Corporation Begins Pre-Clinical Trials on Human Corneal Epithelial Cells International Stem Cell Receives Second $1M Tranche Under $5 Million Financing International Stem Cell Begins Pre-Clinical Testing of Its Parthenogenetic Stem Cells for Treatment of Retinal Disease International Stem Cell Corporation Discusses Recent Funding International Stem Cell Corporation Closes Financing 25 26 27 28 29 30 31 32 33 34 35 << < > >>
